CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 0.8050
-0.0200 (-2.42%)
Oct 16, 2026, 3:56 PM GMT
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 9.09 million as of October 16, 2026. It is the 40,470th most valuable company in the world and the 905th biggest in the United Kingdom. Its market cap has increased by 48.82% in one year.
Market Cap
9.09M
Enterprise Value
7.53M
Revenue
1.15M
Global Rank
Country Rank
#905 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 9.09M, a decrease of -55.37%. That is a compound annual growth rate of -3.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 9.09M | -27.27% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.31B |
| GSK plc | 74.09B |
| Haleon | 32.67B |
| Smith & Nephew | 9.14B |
| Aptamer Group | 11.23M |
| Thalia Therapeutics | 11.10M |
| Palatin Technologies | 10.27M |
| Genflow Biosciences | 10.20M |